PDGF supplementation alters oxidative events in wound healing process: a time course study

[1]  Ş. C. Cevher,et al.  Oxidant and antioxidant events during epidermal growth factor therapy to cutaneous wound healing in rats , 2012, International wound journal.

[2]  C. Heldin.  Autocrine PDGF stimulation in malignancies , 2012, Upsala journal of medical sciences.

[3]  A. Mandal,et al.  Application of a PDGF-containing novel gel for cutaneous wound healing. , 2010, Life sciences.

[4]  L. DiPietro,et al.  Factors Affecting Wound Healing , 2010, Journal of dental research.

[5]  V. Patravale,et al.  Immunological effects and membrane interactions of chitosan nanoparticles. , 2009, Molecular pharmaceutics.

[6]  R. Chen,et al.  In vitro antioxidant activities of low-molecular-weight polysaccharides with various functional groups. , 2009, Journal of agricultural and food chemistry.

[7]  Matthias Schäfer,et al.  Oxidative stress in normal and impaired wound repair. , 2008, Pharmacological research.

[8]  Xiaobing Fu,et al.  Research of PDGF-BB gel on the wound healing of diabetic rats and its pharmacodynamics. , 2008, The Journal of surgical research.

[9]  F. Acartürk,et al.  Effects of Epidermal Growth Factor on Lipid Peroxidation and Nitric Oxide Levels in Oral Mucosal Ulcer Healing: A Time-Course Study , 2007, Surgery Today.

[10]  H. Kantarjian,et al.  Biology of platelet-derived growth factor and its involvement in disease. , 2006, Mayo Clinic proceedings.

[11]  D. Steed.  Clinical Evaluation of Recombinant Human Platelet-Derived Growth Factor for the Treatment of Lower Extremity Ulcers , 2006, Plastic and reconstructive surgery.

[12]  Fatih Zor,et al.  An investigation on burn wound healing in rats with chitosan gel formulation containing epidermal growth factor. , 2006, Burns : journal of the International Society for Burn Injuries.

[13]  Michael J. Terry,et al.  Lentiviral Gene Therapy With Platelet-Derived Growth Factor B Sustains Accelerated Healing of Diabetic Wounds Over Time , 2005, Annals of plastic surgery.

[14]  Junitsu Ito,et al.  NAD(P)H oxidase plays a crucial role in PDGF‐induced proliferation of hepatic stellate cells , 2005, Hepatology.

[15]  M. Jinnin,et al.  Regulation of fibrogenic/fibrolytic genes by platelet‐derived growth factor C, a novel growth factor, in human dermal fibroblasts , 2005, Journal of cellular physiology.

[16]  Andrius Kazlauskas,et al.  PDGF signaling in cells and mice. , 2004, Cytokine & growth factor reviews.

[17]  Ankush Gosain,et al.  Aging and Wound Healing , 2004, World Journal of Surgery.

[18]  Luhang Zhao,et al.  Potential role of nuclear factor-kappaB in the induction of nitric oxide and tumor necrosis factor-alpha by oligochitosan in macrophages. , 2004, International immunopharmacology.

[19]  J. Mason,et al.  Accelerated Diabetic Wound Healing Using Cultured Dermal Fibroblasts Retrovirally Transduced With the Platelet-Derived Growth Factor B Gene , 2003, Annals of plastic surgery.

[20]  Y. Vodovotz,et al.  Nitric oxide and wound repair: role of cytokines? , 2002, Nitric oxide : biology and chemistry.

[21]  J. Pfeilschifter,et al.  Nitric oxide drives skin repair: novel functions of an established mediator. , 2002, Kidney international.

[22]  Makoto Kikuchi,et al.  Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. , 2002, Biomaterials.

[23]  D. Wink,et al.  A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. , 2001, Nitric oxide : biology and chemistry.

[24]  S. Hwang,et al.  Chitinous materials inhibit nitric oxide production by activated RAW 264.7 macrophages. , 2000, Biochemical and biophysical research communications.

[25]  D. Degl'innocenti,et al.  Increased glutathione synthesis associated with platelet-derived growth factor stimulation of NIH3T3 fibroblasts. , 1999, Biochimica et biophysica acta.

[26]  C. Heldin,et al.  Mechanism of action and in vivo role of platelet-derived growth factor. , 1999, Physiological reviews.

[27]  J. Pfeilschifter,et al.  Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. , 1997, The Journal of clinical investigation.

[28]  R. Busse,et al.  Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. , 1997, Circulation.

[29]  Qingrong Chen,et al.  Activation of Cytosolic Phospholipase A2 by Platelet-derived Growth Factor Is Essential for Cyclooxygenase-2-dependent Prostaglandin E2 Synthesis in Mouse Osteoblasts Cultured with Interleukin-1* , 1997, The Journal of Biological Chemistry.

[30]  T. Patel,et al.  The Juxtamembrane, Cytosolic Region of the Epidermal Growth Factor Receptor Is Involved in Association with α-Subunit of Gs* , 1997, The Journal of Biological Chemistry.

[31]  T. Saruta,et al.  Tranilast restores cytokine-induced nitric oxide production against platelet-derived growth factor in vascular smooth muscle cells. , 1996, Journal of cardiovascular pharmacology.

[32]  V. Ferrans,et al.  Requirement for Generation of H2O2 for Platelet-Derived Growth Factor Signal Transduction , 1995, Science.

[33]  I. Fridovich,et al.  Free radicals in cutaneous biology. , 1994, The Journal of investigative dermatology.

[34]  J. Olerud,et al.  Human keratinocytes are a major source of cutaneous platelet-derived growth factor. , 1993, The Journal of clinical investigation.

[35]  P. Vanhoutte,et al.  Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. , 1992, Circulation research.

[36]  G F Pierce,et al.  Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. , 1992, The American journal of pathology.

[37]  D. Bonthron,et al.  PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model , 1991, Cell.

[38]  W. Utian,et al.  Expression of the insulin‐like and platelet‐derived growth factor genes in human uterine tissues , 1990, Molecular reproduction and development.

[39]  A. Taylor,et al.  Relationship between dietary intake and tissue levels of reduced and total vitamin C in the nonscorbutic guinea pig. , 1989, The Journal of nutrition.

[40]  R. Ross,et al.  PLATELET-DERIVED GROWTH FACTOR , 1989, The Lancet.

[41]  W. Richardson,et al.  Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture , 1988, Nature.

[42]  Y. Sun,et al.  A simple method for clinical assay of superoxide dismutase. , 1988, Clinical chemistry.

[43]  A. Casini,et al.  Lipid peroxidation and cellular damage in extrahepatic tissues of bromobenzene-intoxicated mice. , 1986, The American journal of pathology.

[44]  M. Uysal,et al.  The effect of chronic ethanol ingestion on hepatic lipid peroxide, glutathione, glutathione peroxidase and glutathione transferase in rats. , 1985, Toxicology.

[45]  R. Ross,et al.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[46]  F. Acartürk,et al.  Effect of transforming growth factor beta 1 (TGF-beta 1) on nitric oxide production and lipid peroxidation in oral mucosal wound healing , 2009, Medicinal Chemistry Research.

[47]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.